STOCK TITAN
  1. Home
  2. Sec-filings
  3. FBIO
  4. [EFFECT] Fortress Biotech, Inc. SEC Filing

[EFFECT] Fortress Biotech, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 17, 2025 4:00 P.M.
Form: S-1
CIK: 0001429260
Company Name: Fortress Biotech, Inc.
File Number: 333-292154

Source: View Original Filing on SEC EDGAR

Stock FBIO logo
Fortress Biotech Inc

NASDAQ:FBIO

FBIO Rankings

#5048 Ranked by Market Cap
N/A Ranked by Dividends

FBIO Latest News

Jan 13, 2026
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
Dec 15, 2025
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
Dec 10, 2025
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Nov 14, 2025
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights 
Nov 12, 2025
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO Latest SEC Filings

Jan 13, 2026
[8-K] Fortress Biotech, Inc. Reports Material Event
Jan 6, 2026
[SCHEDULE 13D/A] AVENUE THERAPEUTICS, INC. SEC Filing
Dec 18, 2025
[424B3] Fortress Biotech, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Dec 15, 2025
[8-K] Fortress Biotech, Inc. Reports Material Event
Dec 15, 2025
[S-1] Fortress Biotech, Inc. Files IPO Registration Statement

FBIO Stock Data

96.22M
24.66M
20.98%
16.67%
10.17%
Biotechnology
Pharmaceutical Preparations
Link
United States
BAY HARBOR ISLANDS